BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21336996)

  • 1. Factors influencing men's decisions regarding prostate cancer screening: a qualitative study.
    Ferrante JM; Shaw EK; Scott JG
    J Community Health; 2011 Oct; 36(5):839-44. PubMed ID: 21336996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
    Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
    Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of family ties on men's prostate cancer screening, biopsy, and treatment decisions.
    Shaw EK; Scott JG; Ferrante JM
    Am J Mens Health; 2013 Nov; 7(6):461-71. PubMed ID: 23459024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.
    Sheridan SL; Golin C; Bunton A; Lykes JB; Schwartz B; McCormack L; Driscoll D; Bangdiwala SI; Harris RP
    BMC Med Inform Decis Mak; 2012 Nov; 12():130. PubMed ID: 23148458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
    Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
    BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Men's perspectives of prostate cancer screening: A systematic review of qualitative studies.
    James LJ; Wong G; Craig JC; Hanson CS; Ju A; Howard K; Usherwood T; Lau H; Tong A
    PLoS One; 2017; 12(11):e0188258. PubMed ID: 29182649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
    Malli G
    Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.
    Kushalnagar P; Hill C; Carrizales S; Sadler GR
    J Cancer Educ; 2020 Feb; 35(1):28-35. PubMed ID: 30353474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
    Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
    Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
    Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
    J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparing African American Men to Make Informed Prostate Cancer Screening Decisions: Development and Pilot Testing of an Interactive Online Decision Aid.
    Allen JD; Reich A; Cuevas AG; Ladin K
    JMIR Mhealth Uhealth; 2020 May; 8(5):e15502. PubMed ID: 32369032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
    Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
    Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Li J; Zhao G; Hall IJ
    Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing Nigerian men's decision to undergo prostate specific antigen testing.
    Enaworu OU; Khutan R
    Afr Health Sci; 2016 Jun; 16(2):524-32. PubMed ID: 27605968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Younger British men's understandings of prostate cancer: A qualitative study.
    Grogan S; Parlane VL; Buckley E
    J Health Psychol; 2017 May; 22(6):743-753. PubMed ID: 26537520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering the unexpected-Information needs for PSA screening from Men's perspective: A qualitative study.
    Kuss K; Adarkwah CC; Becker M; Donner-Banzhoff N; Schloessler K
    Health Expect; 2021 Aug; 24(4):1403-1412. PubMed ID: 34097797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How underlying patient beliefs can affect physician-patient communication about prostate-specific antigen testing.
    Farrell MH; Murphy MA; Schneider CE
    Eff Clin Pract; 2002; 5(3):120-9. PubMed ID: 12088291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.
    Landrey AR; Matlock DD; Andrews L; Bronsert M; Denberg T
    J Prim Care Community Health; 2013 Jan; 4(1):67-74. PubMed ID: 23799692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.